The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 16, 2009
Filed:
Feb. 12, 2007
Christopher L. Reading, San Diego, CA (US);
Clarence N. Ahlem, San Diego, CA (US);
Dominick L. Auci, San Diego, CA (US);
Charles Dowding, San Diego, CA (US);
James M. Frincke, Carlsbad, CA (US);
Mei LI, San Diego, CA (US);
Theodore M. Page, Carlsbad, CA (US);
Dwight R. Stickney, Granite Bay, CA (US);
Richard J. Trauger, Leucadia, CA (US);
Steven K. White, San Diego, CA (US);
Christopher L. Reading, San Diego, CA (US);
Clarence N. Ahlem, San Diego, CA (US);
Dominick L. Auci, San Diego, CA (US);
Charles Dowding, San Diego, CA (US);
James M. Frincke, Carlsbad, CA (US);
Mei Li, San Diego, CA (US);
Theodore M. Page, Carlsbad, CA (US);
Dwight R. Stickney, Granite Bay, CA (US);
Richard J. Trauger, Leucadia, CA (US);
Steven K. White, San Diego, CA (US);
Hollis-Eden Pharmaceuticals, Inc., San Diego, CA (US);
Abstract
The invention relates to the use of compounds to ameliorate or treat a condition such as a cystic fibrosis, neutropenia or other exemplified conditions. Exemplary compounds that can be used include 3β-hydroxy-17β-aminoandrost-5-ene, 3β-hydroxy-16α-fluoro-17β-aminoandrost-5-ene, 3α-hydroxy-16α-fluoro-17β-aminoandrost-5-ene, 3β-hydroxy-16β-fluoro-17β-aminoandrost-5-ene, 1α,3β-dihydroxy-4α-fluoroandrost-5-ene-17-one, 1α,3β,17β-trihydroxy-4α-fluoroandrost-5-ene, 1β,3β-dihydroxy-6α-bromoandrost-5-ene, 1α-fluoro-3β,12α-dihydroxyandrost-5-ene-17-one, 1α-fluoro-3β,4α-dihydroxyandrost-5-ene and 4α-fluoro-3β,6α,17β-trihydroxyandrostane.